secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001842952-23-000070
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics regains Nasdaq minimum bid price compliance
----------------------------------------------------------------

- Non-compliance with Minimum Bid Price Rule first disclosed on Jan 24, 2023; initial cure period ran to July 24, 2023.
- On June 15, 2023, Nasdaq confirmed the company's common stock had a closing bid price of $1.00+ for 10 consecutive business days.
- Nasdaq considers the matter closed; the company has regained compliance with Listing Rule 5550(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295223000070/0001842952-23-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295223000070/cntx-20230615.htm
  HTML page:      https://secwatch.observer/filing/0001842952-23-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer